Cell-penetrating peptides (CPPs) are short cationic peptides that have been extensively studied as drug delivery vehicles for proteins, nucleic acids and nanoparticles. However, the formulation of CPP-based therapeutics into different pharmaceutical formulations and their stability in relevant biological environments have not been given the same attention. Here, we show that a newly developed CPP, PepFect 14 (PF14), forms non-covalent nanocomplexes with short interfering RNA (siRNA), which are able to elicit efficient RNA-interference (RNAi) response in different cell-lines. RNAi effect is obtained at low siRNA doses with a unique kinetic profile. Furthermore, the solid dispersion technique is utilized to formulate PF14/siRNA nanocomplexes ...
Cell penetrating peptides have demonstrated potential to facilitate the cellular delivery of therape...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
While small interfering RNAs (siRNAs) have been rapidly appreciated to silence genes, efficient and ...
The successful applicability of gene therapy approaches will heavily rely on the development of effi...
The successful applicability of gene therapy approaches will heavily rely on the development of effi...
Tumor-targeted delivery of siRNA remains a major barrier in fully realizing the therapeutic potentia...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
International audienceGene therapy offers the possibility to skip, repair, or silence faulty genes o...
Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles...
Cell-penetrating peptides (CPPs) are highly promising transfection agents that can deliver various c...
The use of gene therapeutics, including short interfering RNA (siRNA), is limited by the lack of eff...
Efficient delivery of small interfering RNA (siRNA) remains the greatest technological barrier to th...
The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the effic...
Cell penetrating peptides have demonstrated potential to facilitate the cellular delivery of therape...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
While small interfering RNAs (siRNAs) have been rapidly appreciated to silence genes, efficient and ...
The successful applicability of gene therapy approaches will heavily rely on the development of effi...
The successful applicability of gene therapy approaches will heavily rely on the development of effi...
Tumor-targeted delivery of siRNA remains a major barrier in fully realizing the therapeutic potentia...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
International audienceGene therapy offers the possibility to skip, repair, or silence faulty genes o...
Delivery of small interfering RNA (siRNA) as a therapeutic tool is limited due to critical obstacles...
Cell-penetrating peptides (CPPs) are highly promising transfection agents that can deliver various c...
The use of gene therapeutics, including short interfering RNA (siRNA), is limited by the lack of eff...
Efficient delivery of small interfering RNA (siRNA) remains the greatest technological barrier to th...
The plasma membrane is a large barrier to systemic drug delivery into cells, and it limits the effic...
Cell penetrating peptides have demonstrated potential to facilitate the cellular delivery of therape...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...